United States Endothelin Receptor Antagonist Market Report 2016

September 2016 | 124 pages | ID: U913245A104EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Endothelin Receptor Antagonist

Revenue, means the sales value of Endothelin Receptor Antagonist

This report studies sales (consumption) of Endothelin Receptor Antagonist in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Actelion Pharmaceuticals Ltd.
• United Therapeutics Corporation
• Gilead sciences
• Bayer AG
• SteadyMed Ltd.
• GlaxoSmithKline plc
• Pfizer Inc.
• Reata Pharmaceuticals Inc.
• Arena Pharmaceuticals Inc.
• Merck & Co. Inc

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Endothelin Receptor Antagonist in each application, can be divided into

• Health care
• Clinic
• Hospital

Contents

United States Endothelin Receptor Antagonist Market Report 2016

1 ENDOTHELIN RECEPTOR ANTAGONIST OVERVIEW

1.1 Product Overview and Scope of Endothelin Receptor Antagonist
1.2 Classification of Endothelin Receptor Antagonist
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Endothelin Receptor Antagonist
  1.3.1 Health care
  1.3.2 Clinic
  1.3.3 Hospital
1.4 USA Market Size Sales (Value) and Revenue (Volume) of Endothelin Receptor Antagonist (2011-2021)
  1.4.1 USA Endothelin Receptor Antagonist Sales and Growth Rate (2011-2021)
  1.4.2 USA Endothelin Receptor Antagonist Revenue and Growth Rate (2011-2021)

2 USA ENDOTHELIN RECEPTOR ANTAGONIST COMPETITION BY MANUFACTURERS

2.1 USA Endothelin Receptor Antagonist Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 USA Endothelin Receptor Antagonist Revenue and Share by Manufactures (2015 and 2016)
2.3 USA Endothelin Receptor Antagonist Average Price by Manufactures (2015 and 2016)
2.4 Endothelin Receptor Antagonist Market Competitive Situation and Trends
  2.4.1 Endothelin Receptor Antagonist Market Concentration Rate
  2.4.2 Endothelin Receptor Antagonist Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 USA ENDOTHELIN RECEPTOR ANTAGONIST SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 USA Endothelin Receptor Antagonist Sales and Market Share by Type (2011-2016)
3.2 USA Endothelin Receptor Antagonist Revenue and Market Share by Type (2011-2016)
3.3 USA Endothelin Receptor Antagonist Price by Type (2011-2016)
3.4 USA Endothelin Receptor Antagonist Sales Growth Rate by Type (2011-2016)

4 USA ENDOTHELIN RECEPTOR ANTAGONIST SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 USA Endothelin Receptor Antagonist Sales and Market Share by Application (2011-2016)
4.2 USA Endothelin Receptor Antagonist Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 USA ENDOTHELIN RECEPTOR ANTAGONIST MANUFACTURERS PROFILES/ANALYSIS

5.1 Actelion Pharmaceuticals Ltd.
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Endothelin Receptor Antagonist Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Actelion Pharmaceuticals Ltd. Endothelin Receptor Antagonist Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 United Therapeutics Corporation
  5.2.2 Endothelin Receptor Antagonist Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 United Therapeutics Corporation Endothelin Receptor Antagonist Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Gilead sciences
  5.3.2 Endothelin Receptor Antagonist Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Gilead sciences Endothelin Receptor Antagonist Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Bayer AG
  5.4.2 Endothelin Receptor Antagonist Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Bayer AG Endothelin Receptor Antagonist Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 SteadyMed Ltd.
  5.5.2 Endothelin Receptor Antagonist Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 SteadyMed Ltd. Endothelin Receptor Antagonist Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 GlaxoSmithKline plc
  5.6.2 Endothelin Receptor Antagonist Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 GlaxoSmithKline plc Endothelin Receptor Antagonist Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Pfizer Inc.
  5.7.2 Endothelin Receptor Antagonist Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Pfizer Inc. Endothelin Receptor Antagonist Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Reata Pharmaceuticals Inc.
  5.8.2 Endothelin Receptor Antagonist Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Reata Pharmaceuticals Inc. Endothelin Receptor Antagonist Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Arena Pharmaceuticals Inc.
  5.9.2 Endothelin Receptor Antagonist Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Arena Pharmaceuticals Inc. Endothelin Receptor Antagonist Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Merck & Co. Inc
  5.10.2 Endothelin Receptor Antagonist Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Merck & Co. Inc Endothelin Receptor Antagonist Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview

6 ENDOTHELIN RECEPTOR ANTAGONIST MANUFACTURING COST ANALYSIS

6.1 Endothelin Receptor Antagonist Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Endothelin Receptor Antagonist

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Endothelin Receptor Antagonist Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Endothelin Receptor Antagonist Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 USA ENDOTHELIN RECEPTOR ANTAGONIST MARKET FORECAST (2016-2021)

10.1 USA Endothelin Receptor Antagonist Sales, Revenue Forecast (2016-2021)
10.2 USA Endothelin Receptor Antagonist Sales Forecast by Type (2016-2021)
10.3 USA Endothelin Receptor Antagonist Sales Forecast by Application (2016-2021)
10.4 Endothelin Receptor Antagonist Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Endothelin Receptor Antagonist
Table Classification of Endothelin Receptor Antagonist
Figure USA Sales Market Share of Endothelin Receptor Antagonist by Type in 2015
Table Application of Endothelin Receptor Antagonist
Figure USA Sales Market Share of Endothelin Receptor Antagonist by Application in 2015
Figure Health care Examples
Figure Clinic Examples
Figure Hospital Examples
Figure USA Endothelin Receptor Antagonist Sales and Growth Rate (2011-2021)
Figure USA Endothelin Receptor Antagonist Revenue and Growth Rate (2011-2021)
Table USA Endothelin Receptor Antagonist Sales of Key Manufacturers (2015 and 2016)
Table USA Endothelin Receptor Antagonist Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Endothelin Receptor Antagonist Sales Share by Manufacturers
Figure 2016 Endothelin Receptor Antagonist Sales Share by Manufacturers
Table USA Endothelin Receptor Antagonist Revenue by Manufacturers (2015 and 2016)
Table USA Endothelin Receptor Antagonist Revenue Share by Manufacturers (2015 and 2016)
Table 2015 USA Endothelin Receptor Antagonist Revenue Share by Manufacturers
Table 2016 USA Endothelin Receptor Antagonist Revenue Share by Manufacturers
Table USA Market Endothelin Receptor Antagonist Average Price of Key Manufacturers (2015 and 2016)
Figure USA Market Endothelin Receptor Antagonist Average Price of Key Manufacturers in 2015
Figure Endothelin Receptor Antagonist Market Share of Top 3 Manufacturers
Figure Endothelin Receptor Antagonist Market Share of Top 5 Manufacturers
Table USA Endothelin Receptor Antagonist Sales by Type (2011-2016)
Table USA Endothelin Receptor Antagonist Sales Share by Type (2011-2016)
Figure USA Endothelin Receptor Antagonist Sales Market Share by Type in 2015
Table USA Endothelin Receptor Antagonist Revenue and Market Share by Type (2011-2016)
Table USA Endothelin Receptor Antagonist Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Endothelin Receptor Antagonist by Type (2011-2016)
Table USA Endothelin Receptor Antagonist Price by Type (2011-2016)
Figure USA Endothelin Receptor Antagonist Sales Growth Rate by Type (2011-2016)
Table USA Endothelin Receptor Antagonist Sales by Application (2011-2016)
Table USA Endothelin Receptor Antagonist Sales Market Share by Application (2011-2016)
Figure USA Endothelin Receptor Antagonist Sales Market Share by Application in 2015
Table USA Endothelin Receptor Antagonist Sales Growth Rate by Application (2011-2016)
Figure USA Endothelin Receptor Antagonist Sales Growth Rate by Application (2011-2016)
Table Actelion Pharmaceuticals Ltd. Basic Information List
Table Actelion Pharmaceuticals Ltd. Endothelin Receptor Antagonist Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Actelion Pharmaceuticals Ltd. Endothelin Receptor Antagonist Sales Market Share (2011-2016)
Table United Therapeutics Corporation Basic Information List
Table United Therapeutics Corporation Endothelin Receptor Antagonist Sales, Revenue, Price and Gross Margin (2011-2016)
Table United Therapeutics Corporation Endothelin Receptor Antagonist Sales Market Share (2011-2016)
Table Gilead sciences Basic Information List
Table Gilead sciences Endothelin Receptor Antagonist Sales, Revenue, Price and Gross Margin (2011-2016)
Table Gilead sciences Endothelin Receptor Antagonist Sales Market Share (2011-2016)
Table Bayer AG Basic Information List
Table Bayer AG Endothelin Receptor Antagonist Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer AG Endothelin Receptor Antagonist Sales Market Share (2011-2016)
Table SteadyMed Ltd. Basic Information List
Table SteadyMed Ltd. Endothelin Receptor Antagonist Sales, Revenue, Price and Gross Margin (2011-2016)
Table SteadyMed Ltd. Endothelin Receptor Antagonist Sales Market Share (2011-2016)
Table GlaxoSmithKline plc Basic Information List
Table GlaxoSmithKline plc Endothelin Receptor Antagonist Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline plc Endothelin Receptor Antagonist Sales Market Share (2011-2016)
Table Pfizer Inc. Basic Information List
Table Pfizer Inc. Endothelin Receptor Antagonist Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Inc. Endothelin Receptor Antagonist Sales Market Share (2011-2016)
Table Reata Pharmaceuticals Inc. Basic Information List
Table Reata Pharmaceuticals Inc. Endothelin Receptor Antagonist Sales, Revenue, Price and Gross Margin (2011-2016)
Table Reata Pharmaceuticals Inc. Endothelin Receptor Antagonist Sales Market Share (2011-2016)
Table Arena Pharmaceuticals Inc. Basic Information List
Table Arena Pharmaceuticals Inc. Endothelin Receptor Antagonist Sales, Revenue, Price and Gross Margin (2011-2016)
Table Arena Pharmaceuticals Inc. Endothelin Receptor Antagonist Sales Market Share (2011-2016)
Table Merck & Co. Inc Basic Information List
Table Merck & Co. Inc Endothelin Receptor Antagonist Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck & Co. Inc Endothelin Receptor Antagonist Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Endothelin Receptor Antagonist
Figure Manufacturing Process Analysis of Endothelin Receptor Antagonist
Figure Endothelin Receptor Antagonist Industrial Chain Analysis
Table Raw Materials Sources of Endothelin Receptor Antagonist Major Manufacturers in 2015
Table Major Buyers of Endothelin Receptor Antagonist
Table Distributors/Traders List
Figure USA Endothelin Receptor Antagonist Production and Growth Rate Forecast (2016-2021)
Figure USA Endothelin Receptor Antagonist Revenue and Growth Rate Forecast (2016-2021)
Table USA Endothelin Receptor Antagonist Production Forecast by Type (2016-2021)
Table USA Endothelin Receptor Antagonist Consumption Forecast by Application (2016-2021)